Validation of the Oxford classification of IgA nephropathy

Kidney International

Volumn 80, Issue 3, 2011, Pages 310-317

  Herzenberg, Andrew M ^a   Fogo, Agnes B ^b   Reich, Heather N ^a   Troyanov, Stéphan ^c   Bavbek, Nuket ^b   Massat, Alfonso E ^d   Hunley, Tracy E ^b   Hladunewich, Michelle A ^b   Julian, Bruce A ^e   Fervenza, Fernando C ^d   Cattran, Daniel C ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b VANDERBILT UNIVERSITY   (United States)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^d MAYO CLINIC   (United States)

^e and Clinical Center   (United States)

Author keywords

clinical epidemiology; glomerulonephritis; IgA nephropathy; pathology; statistics

Indexed keywords

ANTIHYPERTENSIVE AGENT; FISH OIL; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTICLE; CHILD; COHORT ANALYSIS; DISEASE CLASSIFICATION; DRUG USE; FEMALE; FOCAL GLOMERULOSCLEROSIS; GEOGRAPHIC ORIGIN; GLOMERULUS CAPILLARY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CORTEX; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY TUBULE; KIDNEY TUBULE ATROPHY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MESANGIAL HYPERCELLULARITY; MESANGIUM; OXFORD CLASSIFICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; VALIDATION STUDY;

EID: 79960423788     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.126     Document Type: Article

References (28)

1. Bartosik LP, Lajoie G, Sugar L et al. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001; 38: 728-735.
2. Woo KT, Edmondson RP, Wu AY et al. The natural history of IgA nephritis in Singapore. Clin Nephrol 1986; 25: 15-21. (Pubitemid 16187266)
3. Droz D, Kramar A, Nawar T et al. Primary IgA nephropathy: prognostic factors. Contrib Nephrol 1984; 40: 202-207.
4. Geddes CC, Rauta V, Gronhagen-Riska C et al. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 2003; 18: 1541-1548. (Pubitemid 36939626)
5. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000; 36: 227-237. (Pubitemid 30485830)
6. Donadio JV, Bergstralh EJ, Offord KP et al. Clinical and histopathologic associations with impaired renal function in IgA nephropathy. Mayo Nephrology Collaborative Group. Clin Nephrol 1994; 41: 65-71. (Pubitemid 24057162)
7. Johnston PA, Brown JS, Braumholtz DA et al. Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. Q J Med 1992; 84: 619-627. (Pubitemid 23007764)
8. Lee SM, Rao VM, Franklin WA et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol 1982; 13: 314-322. (Pubitemid 12105183)
9. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997; 29: 829-842. (Pubitemid 27251835)
10. Cattran DC, Coppo R, Cook HT et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76: 534-545.
11. Roberts IS, Cook HT, Troyanov S et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 2009; 76: 546-556.
12. Reich HN, Troyanov S, Scholey JW et al. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 2007; 18: 3177-3183. (Pubitemid 350223978)
13. Yamamoto R, Imai E. A novel classification for IgA nephropathy. Kidney Int 2009; 76: 477-480.
14. Bleeker SE, Moll HA, Steyerberg EW et al. External validation is necessary in prediction research: a clinical example. J Clin Epidemiol 2003; 56: 826-832. (Pubitemid 37162656)
15. Toll DB, Janssen KJ, Vergouwe Y et al. Validation, updating and impact of clinical prediction rules: a review. J Clin Epidemiol 2008; 61: 1085-1094.
16. Minutolo R, Balletta MM, Catapano F et al. Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis. Kidney Int 2006; 70: 1170-1176. (Pubitemid 44344089)
17. Miyake-Ogawa C, Miyazaki M, Abe K et al. Tissue-specific expression of renin-angiotensin system components in IgA nephropathy. Am J Nephrol 2005; 25: 1-12. (Pubitemid 40529270)
18. Walsh M, Sar A, Lee D et al. Histopathologic features aid in predicting risk for progression of IgA nephropathy. Clin J Am Soc Nephrol 2010; 5: 425-430.
19. Reilly BM, Evans AT. Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med 2006; 144: 201-209. (Pubitemid 46780691)
20. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med 2000; 19: 453-473. (Pubitemid 30126878)
21. Schumacher M, Hollander N, Sauerbrei W. Resampling and crossvalidation techniques: a tool to reduce bias caused by model building? Stat Med 1997; 16: 2813-2827. (Pubitemid 27520634)
22. Weening JJ, D'Agati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-250. (Pubitemid 38140764)
23. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753-760. (Pubitemid 351347767)
24. Furness PN, Taub N. Interobserver reproducibility and application of the ISN/RPS classification of lupus nephritis-a UK-wide study. Am J Surg Pathol 2006; 30: 1030-1035. (Pubitemid 44264954)
25. Furness PN, Taub N. International variation in the interpretation of renal transplant biopsies: report of the CERTPAP Project. Kidney Int 2001; 60: 1998-2012. (Pubitemid 33000007)
26. Hunter MG, Hurwitz S, Bellamy CO et al. Quantitative morphometry of lupus nephritis: the significance of collagen, tubular space, and inflammatory infiltrate. Kidney Int 2005; 67: 94-102. (Pubitemid 40019230)
27. Mengel M, Chapman JR, Cosio FG et al. Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. Am J Transplant 2007; 7: 512-517. (Pubitemid 46376459)
28. Armstrong GD. The intraclass correlation as a measure of interrater reliability of subjective judgments. Nurs Res 1981; 30: 314-315, 320A.